STATinMED Research Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • STATinMED Research's estimated annual revenue is currently $6.5M per year.(i)
  • STATinMED Research's estimated revenue per employee is $91,800

Employee Data

  • STATinMED Research has 71 Employees.(i)
  • STATinMED Research grew their employee count by -13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.7M33-17%N/AN/A
#2
$5.2M574%N/AN/A
#3
$1.8M25-11%N/AN/A
#4
$1.7M249%N/AN/A
#5
$2.1M29-3%N/AN/A
#6
$1.1M18-14%N/AN/A
#7
$3M37-18%N/AN/A
#8
$6.3M69-3%N/AN/A
#9
$32.4M2895%N/AN/A
#10
$84M6596%N/AN/A
Add Company

STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities. They bring academic and industrial expertise in health economics, pharmacoeconomics, clinical or outcomes research, research design, econometrics, statistics and biostatistics.

keywords:N/A

N/A

Total Funding

71

Number of Employees

$6.5M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

STATinMED Research's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
ProgrammerReveal Email/Phone
3
CEO and CFOReveal Email/Phone
4
SVP, Sales & MarketingReveal Email/Phone
5
VP Strategic Advisory ServicesReveal Email/Phone
6
Senior Research AnalystReveal Email/Phone
7
VP Business Development, HEOR/RWE SolutionsReveal Email/Phone
8
Office ManagerReveal Email/Phone
9
Senior Director, FinanceReveal Email/Phone
10
Manager I, RWEReveal Email/Phone

STATinMED Research News

2022-02-22 - Academic Promotion and Oncology Drug Development: Role ...

Health economics and outcomes research (HEOR) is increasingly being ... She is also the chief medical officer of STATinMED Research,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M71-51%N/A
#2
$20.8M7111%N/A
#3
N/A7127%N/A
#4
$11.5M7131%N/A
#5
$8.8M7244%$2M